Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000030267 | SCV000108048 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030267 | SCV000052934 | benign | Lynch syndrome | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Eurofins Ntd Llc |
RCV000078313 | SCV000110156 | benign | not specified | 2013-02-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000162391 | SCV000212711 | benign | Hereditary cancer-predisposing syndrome | 2019-05-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000078313 | SCV000302877 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000625243 | SCV000430975 | benign | Lynch syndrome 5 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Color Diagnostics, |
RCV000162391 | SCV000537360 | benign | Hereditary cancer-predisposing syndrome | 2015-04-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000756348 | SCV000561540 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625243 | SCV000744298 | benign | Lynch syndrome 5 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000078313 | SCV000884134 | benign | not specified | 2018-09-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668141 | SCV001884663 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000162391 | SCV002528011 | benign | Hereditary cancer-predisposing syndrome | 2021-05-11 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000078313 | SCV002552337 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000625243 | SCV004015982 | benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000030267 | SCV004835045 | benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001668141 | SCV005243567 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000078313 | SCV000257249 | benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353933 | SCV000592634 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The p.Thr1102Thr variant has been identified in 27 out of 966 proband chromosomes (frequency 0.028) in individuals with breast, prostate and colorectal cancers, however no normal population controls were included in these studies (Chan 1999, Kolodner 1999, Vahteristo 2005, Colley 2005, Damaraju 2006). However, this variant is listed in dbSNP database (ID#: rs2020910) with an average heterozygosity of 0.053+/-0.154, increasing the likelihood that this variant is benign. In addition, this variant is not expected to have clinical significance because it does not alter an amino acid residue, and is not located near a splice junction. In summary, based on the above information this variant is classified as Benign. | |
True Health Diagnostics | RCV000162391 | SCV000788049 | likely benign | Hereditary cancer-predisposing syndrome | 2018-02-15 | no assertion criteria provided | clinical testing | |
Clinical Genetics Laboratory, |
RCV000078313 | SCV001906244 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078313 | SCV001924653 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078313 | SCV001959169 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000078313 | SCV002036257 | benign | not specified | no assertion criteria provided | clinical testing |